{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:39:40Z","timestamp":1791088780776,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.euroneuro.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:32:51Z","timestamp":1375749171000},"page":"1587-1596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["A proof of concept study of tolcapone for pathological gambling: Relationships with COMT genotype and brain activation"],"prefix":"10.1016","volume":"23","author":[{"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Odlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hampshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana R.N.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.07.008_bib1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.npp.1301227","article-title":"Tolcapone improves cognition and cortical information processing in normal human subjects","volume":"32","author":"Apud","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopsych.2008.01.005","article-title":"Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158\/108Met polymorphism","volume":"64","author":"Barnett","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib3","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1523\/JNEUROSCI.4975-05.2006","article-title":"Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain","volume":"26","author":"Bertolino","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling","volume":"14","author":"Blanco","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib5","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopsych.2007.03.031","article-title":"Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls","volume":"63","author":"Diaz-Asper","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopsych.2011.02.027","article-title":"Influence of the COMT genotype on working memory and brain activity changes during development","volume":"70","author":"Dumontheil","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10899-010-9205-1","article-title":"Clinical gender differences among adult pathological gamblers seeking treatment","volume":"27","author":"Echeburua","year":"2011","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2011.12.023","article-title":"COMT Val(158) Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition","volume":"71","author":"Farrell","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jpsychires.2011.09.005","article-title":"A meta-analysis of pathological gaming prevalence and comorbidity with mental health, academic and social problems","volume":"45","author":"Ferguson","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib11","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"First","year":"1995"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-2850.1998.tb00132.x","article-title":"Quality of life therapy and assessment in health care","volume":"5","author":"Frisch","year":"1998","journal-title":"Clin. Psychol. Sci. Pract."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib13","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1038\/npp.2008.82","article-title":"Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism","volume":"33","author":"Giakoumaki","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2006.01380.x","article-title":"Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls","volume":"101","author":"Goudriaan","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psychres.2004.05.006","article-title":"Preliminary validity and reliability testing of a structured clinical interview for pathological gambling","volume":"128","author":"Grant","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","article-title":"A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","volume":"69","author":"Grant","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib18","series-title":"Clinical Global Impressions.","first-page":"218","author":"Guy","year":"1976"},{"issue":"10","key":"10.1016\/j.euroneuro.2013.07.008_bib19","doi-asserted-by":"crossref","first-page":"e48135","DOI":"10.1371\/journal.pone.0048135","article-title":"Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome","volume":"7","author":"Hall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib23","unstructured":"Hampshire, A., MacDonald, A., Owen, A.M., Hubbard, D., 2013. Functional Abnormalities in Retired American Professional Football Players and Matched Controls. (submitted for publication)."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib24","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(10)62185-X","article-title":"Gambling disorders","volume":"378","author":"Hodgins","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1471-4159.1994.63030972.x","volume":"63","author":"Karoum","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.008","article-title":"The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study","volume":"166","author":"Kim","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10899-010-9237-6","article-title":"Executive function in pathological gamblers and healthy controls","volume":"28","author":"Ledgerwood","year":"2012","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib30","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/bi00013a008","article-title":"Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme","volume":"34","author":"Lotta","year":"1995","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.euroneuro.2013.07.008_bib31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2009.36","article-title":"Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis","volume":"15","author":"Mier","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2013.07.008_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archneur.57.2.263","article-title":"Tolcapone and hepatotoxic effects. Tasmar Advisory Panel","volume":"57","author":"Olanow","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0028-3932(90)90137-D","article-title":"Planning and spatial working memory following frontal lobe lesions in man","volume":"28","author":"Owen","year":"1990","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","article-title":"Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)","volume":"21","author":"Pallanti","year":"2005","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.758679","article-title":"Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity","volume":"203","author":"Scanlon","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","article-title":"Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis","volume":"89","author":"Shaffer","year":"1999","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1098\/rstb.1982.0082","article-title":"Specific impairments of planning","volume":"298","author":"Shallice","year":"1982","journal-title":"Philos. Trans. R. Soc. London Ser. B: Biol. Sci."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1017\/S1092852900021416","article-title":"The effect of pathological gambling on families, marriages, and children","volume":"12","author":"Shaw","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib39","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1874473711104020067","article-title":"A critical review of treatment approaches for gambling disorders","volume":"4","author":"Stea","year":"2011","journal-title":"Curr. Drug Abuse Rev."},{"issue":"11","key":"10.1016\/j.euroneuro.2013.07.008_bib41","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/sj.npp.1300787","article-title":"COMT polymorphisms and anxiety-related personality traits","volume":"30","author":"Stein","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.07.008_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ADM.0b013e3182307dbb","article-title":"Hesitation to seek gambling-related treatment among Ontario problem gamblers","volume":"6","author":"Suurvali","year":"2012","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10899-009-9151-y","article-title":"Motivators for resolving or seeking help for gambling problems: a review of the empirical literature","volume":"26","author":"Suurvali","year":"2010","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib44","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1523\/JNEUROSCI.1124-04.2004","article-title":"Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex","volume":"24","author":"Tunbridge","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2009.07.007","article-title":"Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling","volume":"34","author":"van Holst","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2013.07.008_bib46","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0774-07.2007","article-title":"Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease","volume":"27","author":"Williams-Gray","year":"2007","journal-title":"J. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13002083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13002083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T00:25:18Z","timestamp":1539476718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13002083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924977X13002083"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.07.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A proof of concept study of tolcapone for pathological gambling: Relationships with COMT genotype and brain activation","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}